NCT02832973View on ClinicalTrials.gov

Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2018

Conditions
Hypertension Resistant to Conventional Therapy
Interventions
DRUG

Spironolactone

Spironolactone 25 mg

DRUG

Furosemide,

Furosemide 20-40 mg

DRUG

Amiloride

Amiloride 5 mg

DRUG

Ramipril

Ramipril 5-10 mg

DRUG

Bisoprolol

Bisoprolol 5-10 mg

Trial Locations (1)

15090000

Juan Carlos Yugar-Toledo, São José do Rio Preto

All Listed Sponsors
lead

Sao Jose do Rio Preto Medical School

OTHER

NCT02832973 - Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension | Biotech Hunter | Biotech Hunter